Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard S Gold

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|February 25, 2005
Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, IsraelJacob Schlesinger, Shiri Navon-Venezia, Inna Chmelnitsky, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemicCatherine Li, Ryan W Chapin, Nicholas J Mercuro, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2007
Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureusAthanassios Tsakris, Satish K Pillai, Howard S Gold, et al.
JAMA Cardiology|September 16, 2020
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)Nicholas J Mercuro, Christina F Yen, David J Shim, et al.
Infection Control and Hospital Epidemiology|June 21, 2016
Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?Westyn Branch-Elliman, Maggie Stanislawski, Judith Strymish, et al.
Open Forum Infectious Diseases|May 9, 2017
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative <i>Clostridium difficile</i> Infection?Mary T LaSalvia, Westyn Branch-Elliman, Graham M Snyder, et al.
Chemotherapy|April 10, 2019
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsCorey C Burrelli, Eleanor K Broadbent, Alice Margulis, et al.
Emerging Infectious Diseases|June 5, 2003
Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremiaMitchell J Schwaber, Sharon B Wright, Yehuda Carmeli, et al.
The Journal of Infectious Diseases|June 25, 2004
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNAVenkata G Meka, Satish K Pillai, George Sakoulas, et al.
Leukemia & Lymphoma|June 28, 2018
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumabNitipong Permpalung, Monica V Mahoney, Christopher McCoy, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 25, 2005
Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, IsraelJacob Schlesinger, Shiri Navon-Venezia, Inna Chmelnitsky, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemicCatherine Li, Ryan W Chapin, Nicholas J Mercuro, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2007
Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureusAthanassios Tsakris, Satish K Pillai, Howard S Gold, et al.
JAMA Cardiology|September 16, 2020
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)Nicholas J Mercuro, Christina F Yen, David J Shim, et al.
Infection Control and Hospital Epidemiology|June 21, 2016
Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?Westyn Branch-Elliman, Maggie Stanislawski, Judith Strymish, et al.
Open Forum Infectious Diseases|May 9, 2017
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative <i>Clostridium difficile</i> Infection?Mary T LaSalvia, Westyn Branch-Elliman, Graham M Snyder, et al.
Chemotherapy|April 10, 2019
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsCorey C Burrelli, Eleanor K Broadbent, Alice Margulis, et al.
Emerging Infectious Diseases|June 5, 2003
Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremiaMitchell J Schwaber, Sharon B Wright, Yehuda Carmeli, et al.
The Journal of Infectious Diseases|June 25, 2004
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNAVenkata G Meka, Satish K Pillai, George Sakoulas, et al.
Leukemia & Lymphoma|June 28, 2018
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumabNitipong Permpalung, Monica V Mahoney, Christopher McCoy, et al.
Pageof 5